Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Nicolette A. Louissaint To Join HDA as Senior Vice President, Policy and Strategic Planning
The Healthcare Distribution Alliance (HDA) is pleased to announce that Nicolette A. Louissaint, PhD, MBA, has been named the organization’s Senior Vice President of Policy and Strategic Planning. In this newly created role, Louissaint will become a member of HDA’s Executive Management Team and report to President and Chief Executive Officer Chester “Chip” Davis, Jr. She will join HDA on January 18, 2022, from her current role serving as Executive Director and President of Healthcare Ready in Washington, D.C.
HDA Research Foundation Explores Challenges and Opportunities of Cold Chain Product Distribution
A new publication released by the HDA Research Foundation and Envision Pharma Group — The Future of the U.S. Pharmaceutical Cold Chain — offers strategies to address the remarkable growth of temperature-sensitive products in the healthcare ecosystem — a product class that, as noted in the report, has outpaced non-cold chain therapies by 21 percent between 2018 and 2024.
Cardinal Health Transforming the Supply Chain for COVID-19 and the Future
Protecting the steady supply of critical, lifesaving medicines to hospitals, pharmacies, providers and patients is a complex process in normal times. During COVID-19, patient demand for personal protective equipment (PPE) and other products has escalated significantly, adding new and unique challenges for HDA distributor members who are working around the clock to meet the daily healthcare needs of all Americans.